Document Detail

Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
MedLine Citation:
PMID:  17092303     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The purpose of this study was to examine the correlations between plasma levels of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA) and cardiovascular disease-related traits in a general population and whether these correlations differed between females and males. METHODS: Plasma PAI-1 and t-PA antigen levels and C-reactive protein (CRP), HDL-cholesterol, triglycerides, total cholesterol, systolic blood pressure, diastolic blood pressure, urinary albumin excretion, and glucose were measured in the population-based PREVEND study in Groningen, the Netherlands (n = 2527). RESULTS: Except for CRP and total cholesterol levels, all traits were significantly different between gender (P < 0.001). PAI-1 levels were correlated with all measured cardiovascular disease-related traits (P < 0.01) in both females and males. Except for urinary albumin excretion, similar results, albeit less significant, were found for t-PA levels. Age-adjusted correlations between PAI-1 and CRP, triglycerides, total cholesterol, systolic blood pressure, and diastolic blood pressure differed significantly between females and males (P < 0.01). Many of the gender differences were predominantly present between premenopausal females and males. CONCLUSION: PAI-1 and t-PA levels were correlated with cardiovascular disease-related traits in subjects obtained from the general population and several of these correlations differed across gender. The correlations found in the present study suggest the presence of coordinated patterns of cardiovascular risk factors and indicate which traits might influence PAI-1 and t-PA levels and thereby provide a framework and potential tool for therapeutic intervention to reduce thromboembolic events in the general population.
F W Asselbergs; S M Williams; P R Hebert; C S Coffey; H L Hillege; G Navis; D E Vaughan; W H van Gilst; J H Moore
Related Documents :
3696353 - Atherogenesis and hypertension.
18227493 - Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without ...
22928143 - Surgical ligation of extrahepatic shunt under guidance of doppler ultrasound, portograp...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-11-09
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  5     ISSN:  1538-7933     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-02     Completed Date:  2007-03-19     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  England    
Other Details:
Languages:  eng     Pagination:  313-20     Citation Subset:  IM    
Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Blood Pressure
Cardiovascular Diseases / blood,  etiology*
Middle Aged
Netherlands / epidemiology
Plasminogen Activator Inhibitor 1 / blood*
Risk Factors
Sex Factors
Tissue Plasminogen Activator / blood*
Grant Support
Reg. No./Substance:
0/Biological Markers; 0/Plasminogen Activator Inhibitor 1; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of...
Next Document:  Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surfac...